遠地點企業公司 APOG 深 滬
已收盤 12-05 16:00:00 美东时间
37.65
+0.070
+0.19%
華盛通- 最 高37.8897
- 今 開37.31
- 成交量 9.41万股
- 最 低 37.29
- 昨 收 37.58
- 總市值 8.10亿
- 52周最高 76.685
- 市盈率 靜 9.69
- 換手率 0.00%
- 52周最低 32.77
- 委 比 -92.80%
- 總股本 2151.09万
- 歷史最高 86.885
- 量 比 0.75
- 振 幅 1.60%
- 歷史最低 -0.923
- 每 手 1
- 風險率 10.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
11-18 15:28
DA Davidson Upgrades Apogee Enterprises to Buy, Announces $47 Price Target
DA Davidson analyst Brent Thielman upgrades Apogee Enterprises (NASDAQ:APOG) from Neutral to Buy and announces $47 price target.
11-17 20:20
Apogee Appoints Donald A. Nolan as New CEO
An announcement from Apogee ( ($APOG) ) is now available. On October 31, 2025, ...
11-06 06:13
Apogee Enterprises announces CEO transition
Apogee Enterprises (APOG) announced that independent chair Donald Nolan has been appointed as the company’s chief executive officer, effective October 31, 2025. Nolan succeeds Ty R. Silberhorn, who de...
10-31 18:54
电话会总结 ｜ Apogee(APOG)2026财年Q2业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Apogee (APOG)的业绩会实录,我总结如下:</p> <p>• 财务业绩: - 第二财季净销售额为3.582亿美元 - 第二财季调整后EBITDA利润率为12.4% - 第二财季调整后每股收益为0.98美元 - 第二财季经营性现金流为5710万美元</p> <p>• 财务指标变化: - 净销售额同比增长4.6% - 调整后EBITDA利润率同比下降 - 调整后每股收益同比下降 - 经营性现金流同比略有下降,从上年同期的5870万美元降至5710万美元 - 年初至今经营性现金流为3730万美元,低于上一财年同期的61
10-11 12:01
Apogee Enterprises Faces Mixed Earnings Call Outlook
Apogee Enterprises (($APOG)) has held its Q2 earnings call. Read on for the mai...
10-11 08:00
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million
Apogee Therapeutics完成8,048,782股普通股的公开募股，每股41美元，总募股额约3.45亿美元。此外，提供365,853股预资助认股权证，总价值约1480万美元，总募资约3.45亿美元。公司专注于炎症和免疫学市场的生物制剂开发，旨在最佳治疗如湿疹、哮喘等疾病。
10-10 20:01
Apogee declares $0.26 dividend
Apogee (NASDAQ:APOG) declares $0.26/share quarterly dividend, in line with previous. Forward yield 2.51% Payable Nov. 13; to shareholders of record Oct. 29; ex-div Oct. 29. The company has now announc...
10-10 18:44
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday
US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.
10-10 14:53
Apogee beats top-line and bottom-line estimates; updates FY26 outlook
Apogee press release (NASDAQ:APOG): Q2 Non-GAAP EPS of $0.98 beats by $0.14. Revenue of $358.19M (+4.6% Y/Y) beats by $7.28M. Adjusted EBITDA decreased to $44.4 million compared to $53.1 million, and ...
10-10 12:57
公司簡介
公司名稱
|
远地点企业公司
|
行業分類
|
建筑材料
|
業務描述
|
Apogee Enterprises, Inc. engages in the design and development of architectural products and services. It also provides architectural glass, aluminum framing systems and installation services for buildings, as well as value-added glazing products for custom picture framing. The company operates through the following segments: Architectural Framing Systems, Architectural Glass, Architectural Services, and Large-Scale Optical Technologies. The Architectural Framing Systems segment designs, engineers, fabricates and finishes aluminum window, curtainwall, storefront and entrance systems comprising the exterior of buildings. The Architectural Glass segment fabricates coated, glass used in custom window and wall systems. The Architectural Services segment integrates technical services, project management, and field installation services to design, engineer, fabricate, and install building glass and curtainwall systems. The Large-Scale Optical Technologies (LSO) segment manufactures value-added coated glass and acrylic products for custom framing, museum, and technical glass markets. The company was founded in 1949 and is headquartered in Minneapolis, MN.
|
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
11-18 15:28
DA Davidson Upgrades Apogee Enterprises to Buy, Announces $47 Price Target
DA Davidson analyst Brent Thielman upgrades Apogee Enterprises (NASDAQ:APOG) from Neutral to Buy and announces $47 price target.
11-17 20:20
Apogee Appoints Donald A. Nolan as New CEO
An announcement from Apogee ( ($APOG) ) is now available. On October 31, 2025, ...
11-06 06:13
Apogee Enterprises announces CEO transition
Apogee Enterprises (APOG) announced that independent chair Donald Nolan has been appointed as the company’s chief executive officer, effective October 31, 2025. Nolan succeeds Ty R. Silberhorn, who de...
10-31 18:54
电话会总结 ｜ Apogee(APOG)2026财年Q2业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Apogee (APOG)的业绩会实录,我总结如下:</p> <p>• 财务业绩: - 第二财季净销售额为3.582亿美元 - 第二财季调整后EBITDA利润率为12.4% - 第二财季调整后每股收益为0.98美元 - 第二财季经营性现金流为5710万美元</p> <p>• 财务指标变化: - 净销售额同比增长4.6% - 调整后EBITDA利润率同比下降 - 调整后每股收益同比下降 - 经营性现金流同比略有下降,从上年同期的5870万美元降至5710万美元 - 年初至今经营性现金流为3730万美元,低于上一财年同期的61
10-11 12:01
Apogee Enterprises Faces Mixed Earnings Call Outlook
Apogee Enterprises (($APOG)) has held its Q2 earnings call. Read on for the mai...
10-11 08:00
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million
Apogee Therapeutics完成8,048,782股普通股的公开募股，每股41美元，总募股额约3.45亿美元。此外，提供365,853股预资助认股权证，总价值约1480万美元，总募资约3.45亿美元。公司专注于炎症和免疫学市场的生物制剂开发，旨在最佳治疗如湿疹、哮喘等疾病。
10-10 20:01
Apogee declares $0.26 dividend
Apogee (NASDAQ:APOG) declares $0.26/share quarterly dividend, in line with previous. Forward yield 2.51% Payable Nov. 13; to shareholders of record Oct. 29; ex-div Oct. 29. The company has now announc...
10-10 18:44
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday
US stock futures up, Apogee Enterprises, Levi Strauss, VolitionRX, USANA Health Sciences, Nurix Therapeutics report results.
10-10 14:53
Apogee beats top-line and bottom-line estimates; updates FY26 outlook
Apogee press release (NASDAQ:APOG): Q2 Non-GAAP EPS of $0.98 beats by $0.14. Revenue of $358.19M (+4.6% Y/Y) beats by $7.28M. Adjusted EBITDA decreased to $44.4 million compared to $53.1 million, and ...
10-10 12:57
派息除權日
|
每股總股息
| 派息日期 |
2025-10-29
|
0.26
|
2025-11-13
|
2025-07-16
|
0.26
|
2025-07-31
|
2025-05-13
|
0.26
|
2025-05-28
|
2025-01-28
|
0.26
|
2025-02-12
|
2024-10-22
|
0.25
|
2024-11-06
|
2024-07-10
|
0.25
|
2024-07-25
|
2024-05-20
|
0.25
|
2024-06-05
|
2024-01-29
|
0.25
|
2024-02-14
|
2023-10-23
|
0.24
|
2023-11-08
|
2023-07-11
|
0.24
|
2023-07-27
|
2023-05-08
|
0.24
|
2023-05-24
|
2023-01-30
|
0.24
|
2023-02-15
|
2022-10-24
|
0.22
|
2022-11-09
|
2022-07-11
|
0.22
|
2022-07-27
|
2022-05-09
|
0.22
|
2022-05-25
|
2022-01-28
|
0.22
|
2022-02-15
|
2021-10-25
|
0.20
|
2021-11-10
|
2021-07-13
|
0.20
|
2021-07-29
|
2021-05-07
|
0.20
|
2021-05-25
|
2021-01-29
|
0.20
|
2021-02-16
|
2020-10-23
|
0.19
|
2020-11-10
|
2020-07-13
|
0.19
|
2020-07-29
|
2020-05-13
|
0.19
|
2020-05-29
|
2020-01-31
|
0.19
|
2020-02-18
|
2019-10-18
|
0.17
|
2019-11-05
|
2019-07-15
|
0.17
|
2019-07-31
|
2019-05-15
|
0.17
|
2019-05-31
|
2019-02-04
|
0.17
|
2019-02-20
|
2018-10-22
|
0.16
|
2018-11-07
|
2018-07-17
|
0.16
|
2018-08-02
|
2018-05-15
|
0.16
|
2018-05-31
|
2018-01-29
|
0.16
|
2018-02-14
|
2017-10-23
|
0.14
|
2017-11-08
|
2017-07-06
|
0.14
|
2017-07-25
|
2017-05-17
|
0.14
|
2017-06-02
|
2017-01-27
|
0.14
|
2017-02-15
|
2016-10-21
|
0.13
|
2016-11-09
|
2016-07-08
|
0.13
|
2016-07-27
|
2016-05-10
|
0.13
|
2016-05-27
|
2016-01-29
|
0.13
|
2016-02-17
|
2015-10-23
|
0.11
|
2015-11-10
|
2015-07-13
|
0.11
|
2015-07-30
|
2015-05-15
|
0.11
|
2015-05-29
|
2015-02-03
|
0.11
|
2015-02-19
|
2014-10-24
|
0.10
|
2014-11-12
|
2014-07-11
|
0.10
|
2014-07-30
|
2014-05-16
|
0.10
|
2014-05-30
|
2014-02-04
|
0.10
|
2014-02-21
|
2013-10-25
|
0.09
|
2013-11-13
|
2013-07-12
|
0.09
|
2013-07-31
|
2013-05-17
|
0.09
|
2013-05-31
|
2013-02-05
|
0.09
|
2013-02-22
|
2012-10-26
|
0.09
|
2012-11-14
|
2012-07-09
|
0.09
|
2012-07-26
|
2012-05-15
|
0.09
|
2012-06-01
|
2012-02-03
|
0.08
|
2012-02-22
|
2011-10-20
|
0.08
|
2011-11-08
|
2011-07-08
|
0.08
|
2011-07-27
|
2011-05-13
|
0.08
|
2011-06-01
|
2011-02-04
|
0.08
|
2011-02-23
|
2010-10-22
|
0.08
|
2010-11-10
|
2010-07-09
|
0.08
|
2010-07-28
|
2010-05-14
|
0.08
|
2010-06-02
|
2010-02-05
|
0.08
|
2010-02-24
|
2009-10-23
|
0.08
|
2009-11-12
|
2009-07-10
|
0.08
|
2009-07-29
|
2009-05-15
|
0.08
|
2009-06-03
|
2009-02-06
|
0.08
|
2009-02-25
|
2008-10-24
|
0.08
|
2008-11-12
|
2008-07-11
|
0.07
|
2008-07-30
|
2008-05-16
|
0.07
|
2008-06-04
|
2008-02-08
|
0.07
|
2008-02-27
|
2007-10-26
|
0.07
|
2007-11-14
|
2007-07-13
|
0.07
|
2007-07-31
|
2007-05-18
|
0.07
|
2007-06-06
|
2007-02-09
|
0.07
|
2007-02-28
|
2006-10-27
|
0.07
|
2006-11-15
|
2006-07-14
|
0.06
|
2006-08-02
|
2006-05-12
|
0.06
|
2006-05-31
|
2006-02-09
|
0.06
|
2006-03-01
|
2005-11-03
|
0.06
|
2005-11-21
|
2005-07-07
|
0.06
|
2005-07-27
|
2005-04-28
|
0.06
|
2005-05-18
|
2005-02-10
|
0.06
|
2005-03-02
|
2004-10-25
|
0.06
|
2004-11-10
|
2004-08-05
|
0.06
|
2004-08-18
|
2004-05-03
|
0.06
|
2004-05-19
|
2004-01-30
|
0.06
|
2004-02-18
|
2003-10-27
|
0.06
|
2003-11-12
|
2003-08-07
|
0.06
|
2003-08-26
|
2003-04-25
|
0.06
|
2003-05-14
|
2003-01-30
|
0.06
|
2003-02-19
|
2002-10-24
|
0.06
|
2002-11-13
|
2002-08-08
|
0.05
|
2002-08-28
|
2002-04-25
|
0.05
|
2002-05-15
|
2002-01-31
|
0.05
|
2002-02-20
|
2001-10-25
|
0.05
|
2001-11-14
|
2001-08-09
|
0.05
|
2001-08-29
|
2001-04-26
|
0.05
|
2001-05-16
|
2001-02-01
|
0.05
|
2001-02-21
|
2000-10-26
|
0.05
|
2000-11-15
|
2000-08-10
|
0.05
|
2000-08-30
|
2000-04-27
|
0.05
|
2000-05-17
|
2000-01-27
|
0.05
|
2000-02-16
|
1999-10-21
|
0.05
|
1999-11-09
|
1999-08-12
|
0.05
|
1999-08-31
|
1999-04-29
|
0.05
|
1999-05-18
|
1999-01-22
|
0.05
|
1999-02-11
|
1998-10-23
|
0.05
|
1998-11-11
|
1998-08-07
|
0.05
|
1998-08-26
|
1998-05-01
|
0.05
|
1998-05-20
|
1998-01-23
|
0.05
|
1998-02-11
|
1997-10-24
|
0.05
|
1997-11-12
|
1997-08-08
|
0.05
|
1997-08-27
|
1997-05-02
|
0.05
|
1997-05-21
|
1997-01-24
|
0.09
|
1997-02-12
|
1996-10-25
|
0.09
|
1996-11-14
|
1996-08-09
|
0.09
|
1996-08-29
|
1996-05-03
|
0.09
|
1996-05-23
|
1996-01-26
|
0.09
|
1996-02-15
|
1995-10-27
|
0.09
|
1995-11-16
|
1995-08-11
|
0.08
|
1995-08-31
|
1995-05-03
|
0.08
|
1995-05-25
|
1995-01-25
|
0.08
|
1995-02-16
|
1994-10-26
|
0.08
|
1994-11-17
|
1994-08-10
|
0.08
|
1994-09-01
|
1994-05-04
|
0.08
|
1994-05-26
|
1994-01-26
|
0.08
|
1994-02-17
|
1993-10-27
|
0.08
|
1993-11-18
|
1993-08-03
|
0.07
|
1993-08-25
|
1993-05-04
|
0.07
|
1993-05-26
|
1993-01-26
|
0.07
|
1993-02-18
|
1992-10-27
|
0.07
|
1992-11-19
|
1992-08-04
|
0.06
|
1992-08-27
|
1992-05-05
|
0.06
|
1992-05-29
|
1992-01-28
|
0.06
|
1992-02-20
|
1991-10-29
|
0.06
|
1991-11-20
|
1991-08-06
|
0.06
|
1991-08-28
|
1991-05-07
|
0.06
|
1991-05-30
|
1991-01-30
|
0.06
|
1991-02-21
|
1990-10-31
|
0.06
|
1990-11-21
|
1990-08-08
|
0.06
|
1990-08-29
|
1990-05-02
|
0.06
|
1990-05-23
|
1990-01-29
|
0.05
|
1990-02-15
|
1989-11-01
|
0.05
|
1989-11-16
|
1989-08-07
|
0.05
|
1989-08-29
|
1989-05-01
|
0.05
|
1989-05-23
|
1989-01-30
|
0.04
|
1989-02-16
|
1988-10-31
|
0.04
|
1988-11-16
|
1988-08-08
|
0.04
|
1988-08-24
|
1988-05-09
|
0.04
|
1988-05-26
|
1988-02-03
|
0.04
|
1988-02-25
|
1987-11-04
|
0.04
|
1987-11-24
|
1987-08-10
|
0.04
|
1987-08-28
|
1987-05-04
|
0.03
|
1987-05-22
|
1987-02-03
|
0.03
|
1987-02-23
|
1986-11-04
|
0.03
|
1986-11-25
|
1986-07-31
|
0.04
|
1986-08-20
|
1986-04-28
|
0.04
|
1986-05-16
|
1986-02-03
|
0.04
|
1986-02-19
|
1985-11-06
|
0.04
|
1985-11-22
|
1985-08-01
|
0.04
|
1985-08-22
|
1985-04-30
|
0.03
|
1985-05-17
|
1985-02-04
|
0.03
|
1985-02-21
|
1984-10-31
|
0.03
|
1984-11-23
|
1984-08-01
|
0.03
|
1984-08-17
|
1984-05-04
|
0.03
|
1984-05-23
|
1984-01-30
|
0.03
|
1984-02-17
|
1983-11-01
|
0.04
|
1983-11-18
|
1983-08-01
|
0.04
|
1983-08-19
|
1983-05-11
|
0.03
|
1983-05-27
|
1983-02-03
|
0.03
|
1983-02-25
|
1982-11-03
|
0.04
|
1982-11-26
|
1982-08-02
|
0.04
|
1982-08-20
|
1982-05-03
|
0.03
|
1982-05-21
|
1982-02-04
|
0.03
|
1982-02-26
|
1981-11-02
|
0.04
|
1981-11-23
|
1981-08-05
|
0.04
|
1981-08-28
|
1981-04-29
|
0.04
|
1981-05-22
|
1981-02-05
|
0.03
|
1981-02-27
|
1980-11-25
|
0.25
|
1980-11-24
|
1980-10-31
|
0.03
|
1980-11-24
|
1980-08-06
|
0.03
|
1980-08-29
|
1980-05-01
|
0.03
|
1980-05-23
|
1980-02-05
|
0.03
|
1980-02-28
|
1979-10-29
|
0.03
|
1979-11-25
|
1979-08-01
|
0.03
|
1979-08-23
|
1979-05-02
|
0.03
|
1979-05-24
|
1979-02-05
|
0.03
|
1979-03-01
|
1978-10-30
|
0.03
|
1978-11-26
|
1978-07-25
|
0.03
|
1978-08-20
|
1978-05-03
|
0.03
|
1978-05-29
|
1978-02-01
|
0.03
|
1978-02-23
|
1977-11-02
|
0.03
|
1977-11-29
|
1977-08-02
|
0.04
|
1977-08-21
|
1977-05-10
|
0.04
|
1977-05-29
|
